IMM.L
ImmuPharma PLC
Price:  
1.11 
GBP
Volume:  
1,466,186.00
United Kingdom | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IMM.L WACC - Weighted Average Cost of Capital

The WACC of ImmuPharma PLC (IMM.L) is 9.2%.

The Cost of Equity of ImmuPharma PLC (IMM.L) is 13.80%.
The Cost of Debt of ImmuPharma PLC (IMM.L) is 5.00%.

Range Selected
Cost of equity 10.10% - 17.50% 13.80%
Tax rate 9.00% - 11.30% 10.15%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.3% - 11.0% 9.2%
WACC

IMM.L WACC calculation

Category Low High
Long-term bond rate 4.0% 4.5%
Equity market risk premium 6.0% 7.0%
Adjusted beta 1.02 1.8
Additional risk adjustments 0.0% 0.5%
Cost of equity 10.10% 17.50%
Tax rate 9.00% 11.30%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 7.3% 11.0%
Selected WACC 9.2%